Magnetic resonance imaging (MRI) and spectroscopy course
Course dates
Monday 13th – Wednesday 15th October 2025
Venue
The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, UK.
Overview
This course is organised by the Joint Department of Physics of The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.
The course has been running at the current venue since 1998. It gives an introduction to methods and applications of biomedical magnetic resonance imaging (MRI) and spectroscopy, assuming no prior knowledge of the principles of magnetic resonance.
The course is intended to be useful both for NHS physicists who deal with MRI in a clinical setting, and for scientists (such as postdocs and PhD students new to the field) performing research in the field of in vivo NMR. It includes the opportunity to virtually observe measurements demonstrated on one of the Siemens 1.5T MR systems, installed at The Royal Marsden NHS Foundation Trust. A provisional lecture list is available below.
The course assumes some familiarity with general principles of physics, but no specific knowledge of magnetic resonance.
Group tutorials are included to give students the opportunity to discuss the material in small groups, and to perform simple exercises to reinforce and extend the teaching of the formal lectures.
The course begins at 9.30am on Monday 14 October 2024, and finishes late afternoon on Wednesday 16 October 2024. One-and-a-half-hour group demonstrations may be included as part of the course on the Monday or Tuesday evenings.
This is a CPD course approved by IPEM.
Provisional lecture list
- Basis of NMR
- Relaxation Parameters and Spin Echoes
- Magnetic Field Gradients, Slice Selection and Frequency Encoding
- Basic Imaging Sequences: Spin-echo and Gradient Echo
- 2D FT Imaging, k-space
- Hardware - RF Requirements and RF Coils
- Safety Considerations
- Hardware - Magnets, Gradients and Eddy Currents
- Image Contrast, Resolution and Factors Affecting Signal-to-Noise
- MRI in Practice
- MRI in Radiotherapy Planning
- K-space trajectories
- Quantitative imaging
- Acceleration of MR sequences
- Diffusion MRI
- Introduction to in vivo MR Spectroscopy
- MR Spectroscopy Acquisition and Analysis
- MRI for Clinical Drug Development
- Flow and MR Angiography
- Functional Imaging Methods
- Clinical examples of MRI
Most lectures will be 45 minutes in duration.
Provisional list of lecturers
- Dr M Blackledge – ICR and RMH, Sutton
- Dr G Charles-Edwards – Guy's and St Thomas Hospitals, London and ICR
- Dr K De Paepe – Cambridge
- Dr S Doran – ICR and RMH, Sutton
- Dr M Graves – Addenbrookes Hospital, Cambridge
- Dr E Kousi – ICR and RMH, Sutton
- Dr P Murphy – The Janssen Pharmaceutical Companies of Johnson & Johnson
- Dr M Orton - RMH and ICR, Sutton
- Dr GS Payne – ICR and RMH, Sutton
- Dr M Rata – ICR and RMH, Sutton
- Dr M Schmidt – ICR and RMH, Sutton
- Professor G Barker – Kings College, London
- Dr J Winfield – RMH and ICR, Sutton
Registration & Course fees
All current course registration fees are given on our registration form.
The cost includes lunches and light refreshments. Lecture notes and a certificate of attendance are provided.
You will be allocated a place on receipt of a completed registration form and a valid quoted payment reference/purchase order or completed bank transfer/online payment. We are unable to accept provisional bookings.
The number of participants is limited, so early booking is advised. Applications from outside the UK are welcome.
Closing date for registrations - Friday 3rd October 2025
Related documents
Contacts
Course Organiser: Dr Simon Doran
For registration details and any other queries contact:
Course Administrator: Mrs Melisa Porter

Related pages
Latest ICR News
).jpg?sfvrsn=83bdab30_1)
Genetic study links common form of testicular cancer to rare variants in cell structure genes
The largest study to date of most common form of testicular cancer has uncovered a possible link between disease risk and variations in the genes controlling cell shape and movement.

Overuse of CT scans could cause 100,000 extra cancers in US
The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned.

ICR welcomes NICE recommendation of capivasertib for advanced breast cancer
The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most common type of advanced breast cancer with specific biomarker alterations (PIK3CA, AKT1 or PTEN).

Simple spit test could finally turn the tide on prostate cancer
A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, according to a study by ICR scientists.